Rchr
J-GLOBAL ID:201501011718942185   Update date: Jun. 25, 2024

Teruya Kenta

テルヤ ケンタ | Teruya Kenta
Affiliation and department:
Job title: Associate Professor
Homepage URL  (2): https://www.neurochemistry.med.tohoku.ac.jp/https://www.neurochemistry.med.tohoku.ac.jp/NC/NC_teruya.html
Research field  (2): Virology ,  Biochemistry
Research keywords  (5): 凝集蛋白質 ,  ペプチド化学 ,  プリオン病 ,  蛋白質化学 ,  プリオン
Research theme for competitive and other funds  (9):
  • 2023 - 2026 Molecular Mechanisms of Spine Disruption Developed from Mouse Strain Differences in Antiprion Drug Susceptibility
  • 2019 - 2022 賦形剤の薬効?
  • 2016 - 2019 Analysis of host genetic factors associated with disease suppression against prion diseases.
  • 2015 - 2017 細胞上での蛋白質凝集体のモノマー間インターフェイスの解明
  • 2011 - 2013 Enhancement by liposome of semi-synthesis of specifically modified protein at the C-terminal and application to living cell
Show all
Papers (64):
  • Kenta Teruya, Ayumi Oguma, Sara Iwabuchi, Keiko Nishizawa, Katsumi Doh-ura. Improvement of anti-prion efficacy with stearoxy conjugation of hydroxypropyl methylcellulose in prion-infected mice. Carbohydrate Polymers. 2024. 337
  • Hitaru Kishida, Atsushi Kobayashi, Kenta Teruya, Hiroshi Doi, Naohisa Ueda, Fumiaki Tanaka, Yoshiyuki Kuroiwa, Piero Parchi, Shirou Mohri, Tetsuyuki Kitamoto. Transmission experiments verify sporadic V2 prion in a patient with E200K mutation. Acta Neuropathologica. 2024. 147. 1
  • Ayaka Okawara, Keigo Hada, Reiko Kurotani, Kenta Teruya, Hiroyuki Konno. Design of the peptide C-terminus protecting group and application for the peptide fragment coupling reaction. Tetrahedron Letters. 2023. 127
  • 照屋健太, 堂浦克美. 治療法開発状況. Clinical Neuroscience. 2023. 41. 9. 1240-1243
  • Kenta Teruya, Katsumi Doh-Ura. Therapeutic development of polymers for prion disease. Cell and tissue research. 2023. 392. 1. 349-365
more...
MISC (28):
Patents (7):
more...
Books (3):
  • 最新アミロイドーシスのすべて
    医歯薬出版 2017
  • Medical Bio
    オーム社 2010
  • KEY WORD感染症 第2版
    先端医学社 2008
Lectures and oral presentations  (30):
  • Candidate drugs for treatment of prion diseases.
    (Asia Pacific Prion Symposium 2023 2023)
  • Our quest for anti-prion compound 2022
    (Asia Pacific Prion Symposium 2022)
  • プリオン病治療薬開発の現状
    (第62回日本神経学会学術大会 シンポジウム「プリオン病の創薬と早期診断」 2021)
  • プリオン病治療法開発の現状と展望
    (2018年度 プリオン病のサーベイランスと対策に関する全国担当者会議 2019)
  • Our efforts and state in developing anti-prion chemicals based on mouse models
    (PRION 2018 2018)
more...
Education (3):
  • 1999 - 2002 Osaka University Graduate School, Division of Natural Science
  • 1997 - 1999 大阪大学大学院 理学研究科 博士前期課程
  • 1993 - 1997 Osaka University Faculty of Science 化学科
Professional career (1):
  • 博士(理学) (Osaka University)
Work history (5):
  • 2015/04 - 現在 Tohoku University Graduate School of Medicine
  • 2010/07 - 2015/03 京都府立医科大学大学院医学研究科 准教授
  • 2003/10 - 2010/06 Tohoku University Graduate School of Medicine
  • 2002/07 - 2003/09 National Institutes for Health National Cancer Institute Visitting Fellow
  • 2002/04 - 2002/06 Osaka University Institute for Protein Research
Committee career (1):
  • 2017/10 - 現在 Asian Pacific Society of Prion Research Counsilar
Association Membership(s) (5):
THE SOCIETY OF SYNTHETIC ORGANIC CHEMISTRY, JAPAN ,  Asian Pacific Society of Prion Research (APSPR) ,  PROTEIN SCIENCE SOCIETY OF JAPAN ,  THE CHEMICAL SOCIETY OF JAPAN ,  The Japanese Peptide Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page